Walleye Trading’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27
Closed -$5K 5190
2022
Q1
$5K Sell
27
-286
-91% -$59.2K ﹤0.01% 5097
2021
Q4
$84K Sell
313
-660
-68% -$173K ﹤0.01% 4467
2021
Q3
$284K Sell
973
-14
-1% -$4.09K ﹤0.01% 3508
2021
Q2
$244K Buy
987
+587
+147% +$151K ﹤0.01% 3737
2021
Q1
$114K Buy
+400
New +$160K ﹤0.01% 4020

Other funds holding CODX

Walleye Trading's CODX Position: Q3 2022 in Review

Walleye Trading sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 1,127 shares — an estimated $190K sold.

Walleye Trading first reported a position in CODX in Q1 2021 and held it in 4 quarters. The position peaked at $190K in Q2 2022. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • Walleye Trading reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 1,127 Co-Diagnostics shares in Q3 2022, an estimated $190K.
  • Walleye Trading first reported a position in Co-Diagnostics in Q1 2021 and held it in 4 quarters.
  • Walleye Trading's Co-Diagnostics position peaked at $190K in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.